Pharmaceutical packaging, one of the most innovative sectors in Italy, plays a key role in ensuring product integrity, traceability and compliance with EU regulatory requirements. The ability to trace the path of a medicine along the entire distribution chain is essential to prevent counterfeiting, which not only harms manufacturers but also compromises patient safety. This mechanism is also indispensable for…
Biological medicines are products derived from living organisms, used in the treatment of serious diseases such as diabetes, cancer, and autoimmune diseases. The active ingredients in these medicines are more complex, compared to non-biological products, so they require much more development time and cost, which limits patients' access to treatment. Biosimilar medicines, which have been used in the European Union…
The pharmaceutical packaging sector boasts standards of innovation and excellence, which in recent years have contributed greatly to strengthening European and Italian leadership on the global stage. It therefore needs qualified profiles and 4.0 skills that can facilitate digital transition and sustainable development. This translates into hiring opportunities and career possibilities faster than in other areas, particularly for profiles capable…
Despite difficulties in supplies and the rising cost of raw materials, the Italian pharmaceutical industry still grew in 2022. Production was up 10 percent, with a total value of 38 billion euros and a 44 percent increase in exports. Signs that confirm the excellence of the Italian pharmaceutical supply chain, first in Europe with results that far exceed the main…
Innovation is a competitive advantage for European companies, which is essential to go along with the ecological transition, revitalise the economy, and ensure the well-being of citizens. The EU's anti-crisis strategies aim to strengthen autonomy in key high-innovation sectors such as pharma, which employed 840,000 people in 2021 and recorded a production value of €300 billion. "As well as driving…
Health and sustainability are closely related issues, involving environmental, economic and social aspects. Among the main challenges facing the Pharma and Healthcare sector today is undoubtedly the need to accelerate the green transition: a priority for institutional agendas, but also for new consumer groups, which are increasingly inclined to buy eco-friendly products. The EU's global strategy, in addition to reaffirming…
Digital natives, by definition, are close relatives to technological innovation. This familiarity is considered an added value by many companies, which decide to invest in the re-skilling and training of new resources by focusing precisely on younger people. To develop new skills and create figures capable of dealing with advanced production processes and increasingly sophisticated machinery. The signs of change…
The pharmaceutical industry is a pillar of the European manufacturing sector, an excellence at global level. Among the countries competing for leadership in the sector are Italy and Germany, at the forefront of research, development and production of new medicines. What determines the volume of R&D investment is the pharmaceutical sector's ability to attract new capital, due to the sector's…
